Demant A/S (WILLF) Stock Price, News & Analysis

Company Overview

Demant A/S, headquartered in Smørum, Denmark, is a global leader in hearing healthcare solutions. The company’s core business centers on the development, manufacturing and distribution of hearing aids, audio processors and related diagnostic equipment. Under its portfolio of brands—including Oticon, Bernafon, Sonic and Oticon Medical—Demant provides advanced technological solutions aimed at improving hearing performance and quality of life for individuals with hearing loss.

Alongside its hearing instruments division, Demant offers a comprehensive range of audiological diagnostic tools and hearing care services. These include digital hearing screening devices, fitting software and outcome measurement systems designed to support hearing care professionals. The group also manages a network of clinics and retail outlets that deliver personalized hearing assessments and rehabilitation services, ensuring a seamless continuum of care from device fitting to follow-up support.

Tracing its heritage back to the founding of Oticon in 1904, the holding company was established in 1992 under the name William Demant Holding A/S before adopting the Demant A/S identity in 2019. Over the decades, the company has expanded its footprint to serve markets in Europe, North and Latin America, Asia Pacific, the Middle East and Africa, drawing on a global research and manufacturing infrastructure to drive innovation and meet regional needs.

Under the leadership of President & CEO Niels Jacobsen, Demant invests heavily in new technologies, including digital signal processing, connectivity solutions and artificial intelligence applications for hearing healthcare. The organization emphasizes collaboration with academic institutions, clinical partners and industry stakeholders to advance evidence-based practices and foster continuous improvement in hearing solutions.

Key Stats

• Today's Range: $38.55 to $38.55
• 50-Day Range: $37.17 to $43.78
• 52-Week Range: $31.85 to $43.78
• Volume: N/A
• Average Volume: 1,163 shs
• Market Capitalization: N/A
• P/E Ratio: 1.67
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Demant A/S Stock Analysis - MarketRank™

Demant A/S scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Demant A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Demant A/S is 1.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of Demant A/S is 1.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.41.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Demant A/S has a short interest ratio ("days to cover") of 1216.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Demant A/S has recently decreased by 8.14%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Demant A/S does not currently pay a dividend.

Dividend Growth

Demant A/S does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Demant A/S has a short interest ratio ("days to cover") of 1216.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Demant A/S has recently decreased by 8.14%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: N/A

News Sentiment

Demant A/S has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Demant A/S this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Demant A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 13.57% of the stock of Demant A/S is held by institutions.

WILLF Stock Analysis - Frequently Asked Questions

How have WILLF shares performed this year?

Demant A/S's stock was trading at $37.04 at the start of the year. Since then, WILLF shares have increased by 4.1% and is now trading at $38.55.

How do I buy shares of Demant A/S?

Shares of WILLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WILLF
• CIK: N/A
• Web: www.demant.com
• Phone: (453) 917-7300
• Fax: N/A
• Employees: 21,623
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.67
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A